A detailed history of Charles Schwab Investment Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 3,001,603 shares of RPRX stock, worth $75.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,001,603
Previous 1,898,262 58.12%
Holding current value
$75.6 Million
Previous $50.1 Million 69.64%
% of portfolio
0.02%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$25.63 - $29.27 $28.3 Million - $32.3 Million
1,103,341 Added 58.12%
3,001,603 $84.9 Million
Q2 2024

Aug 12, 2024

BUY
$26.26 - $29.9 $1.71 Million - $1.95 Million
65,257 Added 3.56%
1,898,262 $50.1 Million
Q1 2024

May 08, 2024

BUY
$27.46 - $31.33 $1.7 Million - $1.94 Million
62,017 Added 3.5%
1,833,005 $55.7 Million
Q4 2023

Feb 06, 2024

BUY
$26.21 - $29.22 $3.2 Million - $3.57 Million
122,084 Added 7.4%
1,770,988 $49.7 Million
Q3 2023

Nov 08, 2023

BUY
$26.26 - $31.38 $4.55 Million - $5.44 Million
173,315 Added 11.75%
1,648,904 $44.8 Million
Q2 2023

Aug 09, 2023

BUY
$29.6 - $36.56 $2.01 Million - $2.49 Million
68,052 Added 4.83%
1,475,589 $45.4 Million
Q1 2023

May 11, 2023

BUY
$32.77 - $39.4 $1.52 Million - $1.83 Million
46,358 Added 3.41%
1,407,537 $50.7 Million
Q4 2022

Feb 13, 2023

BUY
$39.17 - $44.04 $3.29 Million - $3.69 Million
83,896 Added 6.57%
1,361,179 $53.8 Million
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $4.39 Million - $4.91 Million
109,998 Added 9.42%
1,277,283 $51.3 Million
Q2 2022

Aug 15, 2022

BUY
$37.53 - $44.22 $3.49 Million - $4.11 Million
92,864 Added 8.64%
1,167,285 $49.1 Million
Q1 2022

May 13, 2022

BUY
$37.46 - $42.44 $3.23 Million - $3.66 Million
86,335 Added 8.74%
1,074,421 $41.9 Million
Q4 2021

Feb 11, 2022

BUY
$35.17 - $42.48 $1.48 Million - $1.78 Million
41,987 Added 4.44%
988,086 $39.4 Million
Q3 2021

Nov 16, 2021

BUY
$36.14 - $42.24 $24.6 Million - $28.7 Million
680,274 Added 255.91%
946,099 $34.2 Million
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $824,416 - $964,681
20,688 Added 8.44%
265,825 $10.9 Million
Q1 2021

May 17, 2021

BUY
$42.34 - $52.82 $2.74 Million - $3.41 Million
64,636 Added 35.81%
245,137 $10.7 Million
Q4 2020

Feb 16, 2021

SELL
$36.12 - $50.05 $1.24 Million - $1.72 Million
-34,354 Reduced 15.99%
180,501 $9.04 Million
Q3 2020

Nov 13, 2020

BUY
$38.56 - $48.36 $2.05 Million - $2.57 Million
53,188 Added 32.9%
214,855 $9.04 Million
Q2 2020

Aug 14, 2020

BUY
$44.5 - $52.11 $7.19 Million - $8.42 Million
161,667 New
161,667 $7.85 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.